Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, Q.
Right arrow Articles by Rodeck, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, Q.
Right arrow Articles by Rodeck, U.
[Cancer Research 66, 5209-5215, May 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Malignant Transformation of Immortalized HaCaT Keratinocytes through Deregulated Nuclear Factor {kappa}B Signaling

Qing Ren1, Csaba Kari2, Marlene R.D. Quadros2, Randy Burd1, Peter McCue3, Adam P. Dicker1 and Ulrich Rodeck2

Departments of 1 Radiation Oncology, 2 Dermatology and Cutaneous Biology, and 3 Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania

Requests for reprints: Ulrich Rodeck, Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, 233 South 10th Street, BLSB 409, Philadelphia, PA 19107. Phone: 215-503-5622; Fax: 215-503-5622; E-mail: ulrich.rodeck{at}mail.tju.edu and Adam P. Dicker, Department of Radiation Oncology, Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA 19107. Phone: 215-955-6527; Fax: 215-955-0412; E-mail: adam.dicker{at}mail.tju.edu.

Previous studies addressing functional aspects of nuclear factor {kappa}B (NF-{kappa}B) activation in normal and transformed keratinocytes revealed complex and seemingly contradictory roles of this transcription factor in this cell type. In normal skin, NF-{kappa}B signaling seems to inhibit squamous cell carcinoma development whereas, in squamous cell carcinoma themselves, deregulated NF-{kappa}B expression and/or signaling is frequently observed. To further investigate this paradox, we focused on NF-{kappa}B activation as it relates to the transformed phenotype of immortalized but nontumorigenic human keratinocytes (HaCaT cells). We observed that NF-{kappa}B activity contributed to survival and growth of cultured HaCaT keratinocytes as shown by use of pharmacologic NF-{kappa}B inhibitors, RNA interference, and inducible overexpression of a dominant interfering I{kappa}B construct. NF-{kappa}B activation was largely provided through interaction with extracellular matrix components because preventing cell attachment by forced suspension culture markedly reduced NF{kappa}B signaling associated with cell death (anoikis); conversely, anoikis was partially reversed by NF-{kappa}B activation induced either by tumor necrosis factor-{alpha} treatment or by overexpressing the NF-{kappa}B p65 subunit in HaCaT cells. Furthermore, overexpression of NF-{kappa}Bp65 in HaCaT cells induced colony formation in soft agar and tumorigenicity in nude mice. In summary, as opposed to normal keratinocytes, immortalized HaCaT keratinocytes provide a cellular context in which deregulated NF-{kappa}B signaling supports multiple malignant traits in vitro and in vivo. (Cancer Res 2006; 66(10): 5209-15)




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
D. Brennan, Y. Hu, S. Joubeh, Y. W. Choi, D. Whitaker-Menezes, T. O'Brien, J. Uitto, U. Rodeck, and M. G. Mahoney
Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes
J. Cell Sci., March 1, 2007; 120(5): 758 - 771.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Van Waes
Nuclear Factor-{kappa}B in Development, Prevention, and Therapy of Cancer
Clin. Cancer Res., February 15, 2007; 13(4): 1076 - 1082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.